Apple Loses Bid to Overturn $634 Million Masimo Verdict, Plans Appeal
Updated
Updated · 9to5Mac · Jul 21
Apple Loses Bid to Overturn $634 Million Masimo Verdict, Plans Appeal
3 articles · Updated · 9to5Mac · Jul 21
Summary
$634 million in patent damages will stand after a California federal judge denied Apple’s requests for judgment as a matter of law and for a new trial in Masimo’s case.
Judge James V. Selna backed the jury’s finding that Apple Watch qualifies as a “patient monitor” under Masimo’s patent, rejecting Apple’s argument that the term should apply only to conventional medical equipment.
Selna also refused a retrial, finding no serious error in the jury instructions or in the exclusion of testimony from one of Apple’s experts.
Apple said it plans to appeal, arguing Masimo has asserted more than 25 patents over six years and that the patent at issue expired in 2022.
The ruling extends a broader fight that already produced a 2023 U.S. import ban on some blood-oxygen Apple Watches and later software and design changes to keep affected models on sale.